CD8A and graft versus host disease: Its action as an immunosuppressor was demonstrated in vitro and in a mouse model of acute allogeneic GVHD in which it decreased CD8+IFN-γ+ and CD8+ granzyme B+ T cells activation in a dendritic cell-dependent manner and reduced the release of IL-10 (83).